Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE-II-MIX study.


Journal

Bipolar disorders
ISSN: 1399-5618
Titre abrégé: Bipolar Disord
Pays: Denmark
ID NLM: 100883596

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 23 9 2020
medline: 10 8 2021
entrez: 22 9 2020
Statut: ppublish

Résumé

The "Bipolar Disorders: Improving Diagnosis, Guidance, and Education" (BRIDGE-II-Mix) study aimed to estimate the frequency of mixed states in patients with a major depressive episode (MDE) according to different definitions and to compare their clinical validity, looking into specific features such as rapid cycling (RC). Psychiatric symptoms, socio-demographic, and clinical variables were collected from a sample of 2811 MDE patients, of which 726 (25.8%) were diagnosed with bipolar disorder (BD). The characteristics of bipolar patients with RC (BD-RC) and without (BD-NRC) RC were compared. Of 726 BD patients, 159 (21.9%) met DSM-5 criteria for RC. BD-RC group presented a higher number of lifetime depressive episodes (p < 0.001) with shorter duration of depressive episodes, and more psychiatric comorbidities, as well as higher rates of atypical features (p = 0.016) and concomitant (hypo)manic symptoms (irritable mood (p = 0.001); risky behavior (p = 0.005); impulsivity (p = 0.006); and psychomotor agitation (p = 0.029)). Patients with RC had a worse functioning (p = 0.033), more obesity (p = 0.003), and were significantly more likely to be treated with three or more drugs (p = 0.007). Important clinical differences between bipolar patients with and without a RC include more depressive morbidity, higher incidence of anxiety disorders, addiction, bulimia, and borderline personality disorder, as well as atypical features during depression and symptoms such as irritability, risky behavior, impulsivity, and agitation. RC patients had poorer functioning than patients without RC, more obesity, and had to be treated with more drugs.

Identifiants

pubmed: 32959482
doi: 10.1111/bdi.12994
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-399

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry. 1974;30:229-233.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition, Text Rev. Washington, DC: American Psychiatric Association; 2000.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM -5. 5th Edition. Washington DC: American Psychiatric Association; 2013.
Kupka RW, Luckenbaugh DA, Post RM, et al. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry. 2005;162:1273-1280.
Coryell W, Endicott J, Keller M. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry. 1992;49:126-131.
Erol A, Winham SJ, McElroy SL, et al. Sex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder. Bipolar Disord. 2015;17:670-676.
Koukopoulos A, Sani G, Koukopoulos AE, et al. Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. J Affect Disord. 2003;73:75-85.
Erfurth A, Perugi G. Rapid Cycling. In: Kasper S, Hirschfeld RMA, eds. Handbook of Bipolar Disorder. New York; 2005:201-212.
Valentí M, Pacchiarotti I, Undurraga J, et al. Risk factors for rapid cycling in bipolar disorder. Bipolar Disord. 2015;17(5):549-559.
Fountoulakis KN, Kontis D, Gonda X, Yatham LN. A systematic review of the evidence on the treatment of rapid cycling bipolar disorder. Bipolar Disord. 2013;15:115-137.
Nivoli AMA, Colom F, Murru A, et al. New treatment guidelines for acute bipolar depression: A systematic review. J Affect Disord. 2011;129:14-26.
Grunze H. Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectr. 2008;13:790-795.
Parker G, Parker G, Parker K. Which antidepressants flick the switch? Aust N Z J Psychiatry. 2003;37:464-468.
Kukopulos A, Caliari B, Tundo A, et al. Rapid cyclers, temperament, and antidepressants. Compr Psychiatry. 1983;24:249-258.
Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14:154-219.
Ghaemi SN, Ostacher MM, El-Mallakh RS, et al. Antidepressant discontinuation in bipolar depression: a systematic treatment enhancement program for bipolar disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry. 2010;71:372-380.
Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170:1249-1262.
Valentí M, Pacchiarotti I, Bonnín CM, et al. Risk factors for antidepressant-related switch to mania. J Clin Psychiatry. 2012;73:e271-e276.
El-Mallakh RS, Vöhringer PA, Ostacher MM, et al. Antidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trial. J Affect Disord. 2015;184:318-321.
Perugi G, Micheli C, Akiskal HS, et al. Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Compr Psychiatry. 2000;41:13-18.
Garcia-Amador M, Colom F, Valentí M, Horga G, Vieta E. Suicide risk in rapid cycling bipolar patients. J Affect Disord. 2009;117:74-78.
Azorin J-M, Kaladjian A, Adida M, et al. Factors associated with rapid cycling in bipolar I manic patients: findings from a French national study. CNS Spectr. 2008;13:780-787.
Colom F, Vieta E, Daban C, Pacchiarotti I, Sánchez-Moreno J. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord. 2006;93:13-17.
Nierenberg AA, Akiskal HS, Angst J, et al. Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R). Mol Psychiatry. 2010;15:1075-1087.
Perugi G, Angst J, Azorin J-M, et al. Relationships between mixed features and borderline personality disorder in 2811 patients with major depressive episode. Acta Psychiatr Scand. 2016;133:133-143.
Verdolini N, Dean J, Massucci G, et al. Bipolar disorder: The importance of clinical assessment in identifying prognostic factors - an audit. Part 2: mixed state features and rapid cycling. Psychiatr Danub. 2014;26(Suppl 1):s195-s202.
Vieta E, Valentí M. Mixed states in DSM-5: implications for clinical care, education, and research. J Affect Disord. 2013;148:28-36.
Goldberg JF, Wankmuller MM, Sutherland KH. Depression with versus without manic features in rapid-cycling bipolar disorder. J Nerv Ment Dis. 2004;192:602-606.
Valentí M, Pacchiarotti I, Rosa AR, et al. Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients. Bipolar Disord. 2011;13:145-154.
Carvalho AF, Dimellis D, Gonda X, Vieta E, McIntyre RS, Fountoulakis KN. Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry. 2014;75:e578-e586.
Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387:1561-1572.
Perugi G, Angst J, Azorin J-M, et al. Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. J Clin Psychiatry. 2015;76:e351-e358.
Popovic D, Vieta E, Azorin J-M, et al. Suicide attempts in major depressive episode: evidence from the BRIDGE-II-Mix study. Bipolar Disord. 2015;17:795-803.
Schneck CD, Miklowitz DJ, Miyahara S, et al. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2008;165:370-377.
Nivoli AMA, Pacchiarotti I, Rosa AR, et al. Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J Affect Disord. 2011;133:443-449.
Maj M, Magliano L, Pirozzi R, Marasco C, Guarneri M. Validity of rapid cycling as a course specifier for bipolar disorder. Am J Psychiatry. 1994;151:1015-1019.
Yildiz A, Sachs GS. Characteristics of rapid cycling bipolar-I patients in a bipolar speciality clinic. J Affect Disord. 2004;79:247-251.
Cruz N, Vieta E, Comes M, Haro JM, Reed C, Bertsch J. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe. J Psychiatr Res. 2008;42:1068-1075.
Schneck CD, Miklowitz DJ, Calabrese JR, et al. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the systematic treatment enhancement program. Am J Psychiatry. 2004;161(10):1902-1908.
Kupka RW, Luckenbaugh DA, Post RM, Leverich GS, Nolen WA. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry. 2003;64:1483-1494.
Kilzieh N, Akiskal HS. Rapid-cycling bipolar disorder. An overview of research and clinical experience. Psychiatr Clin North Am. 1999;22:585-607.
Bauer M, Beaulieu S, Dunner DL, Lafer B, Kupka RW. Rapid cycling bipolar disorder-diagnostic concepts. Bipolar Disord. 2008;10:153-162.
Lish JD, Gyulai L, Resnick SM, et al. A family history study of rapid-cycling bipolar disorder. Psychiatry Res. 1993;48:37-46.
Hajek T, Hahn M, Slaney C, et al. Rapid cycling bipolar disorders in primary and tertiary care treated patients. Bipolar Disord. 2008;10:495-502.
Lee S, Tsang A, Kessler RC, et al. Rapid-cycling bipolar disorder: cross-national community study. Br J Psychiatry. 2010;196:217-225.
Verdolini N, Agius M, Ferranti L, Moretti P, Piselli M, Quartesan R. The State of the Art of the DSM-5 “with Mixed Features” Specifier. Sci World J. 2015;2015:1-7.
Goldberg JF, Perlis RH, Bowden CL, et al. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009;166:173-181.
Vieta E, Grunze H, Azorin J-M, Fagiolini A. Phenomenology of manic episodes according to the presence or absence of depressive features as defined in DSM-5: Results from the IMPACT self-reported online survey. J Affect Disord. 2014;156:206-213.
Garriga M, Pacchiarotti I, Kasper S, et al. Assessment and management of agitation in psychiatry: expert consensus. World J Biol Psychiatry. 2016;17:86-128.
Wu LH, Dunner DL. Suicide attempts in rapid cycling bipolar disorder patients. J Affect Disord. 1993;29:57-61.
Koukopoulos A, Sani G, Koukopoulos AE, Manfredi G, Pacchiarotti I, Girardi P. Melancholia agitata and mixed depression. Acta Psychiatr Scand. 2007;115:50-57.
Sani G, Vöhringer PA, Napoletano F, et al. Koukopoulos׳ diagnostic criteria for mixed depression: a validation study. J Affect Disord. 2014;164:14-18.
Sani G, Vöhringer PA, Barroilhet SA, Koukopoulos AE, Ghaemi SN. The Koukopoulos Mixed Depression Rating Scale (KMDRS): An International Mood Network (IMN) validation study of a new mixed mood rating scale. J Affect Disord. 2018;232:9-16.
Vieta E, Blasco-Colmenares E, Figueira ML, Langosch JM, Moreno-Manzanaro M, Medina E. Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd Study). BMC Psychiatry. 2011;11:1-8.
Maremmani AGI, Dell’Osso L, Pacini M, et al. Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin. J Addict Dis. 2011;30:123-135.
Gao K, Chan PK, Verduin ML, et al. Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders. Am J Addict. 2010;19:440-449.
Keller MB. Prevalence and impact of comorbid anxiety and bipolar disorder. J Clin Psychiatry. 2006;67(Suppl 1):5-7.
Boylan KR, Bieling PJ, Marriott M, Begin H, Young LT, MacQueen GM. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry. 2004;65:1106-1113.
McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158(3):420-426.
Nabavi B, Mitchell AJ, Nutt D. A lifetime prevalence of comorbidity between bipolar affective disorder and anxiety disorders: a meta-analysis of 52 interview-based studies of psychiatric population. EBioMedicine. 2015;2:1405-1419.
Angst J, Gamma A, Bowden CL, et al. Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity. Eur Arch Psychiatry Clin Neurosci. 2013;263:663-673.
Mosolov S, Ushkalova A, Kostukova E, et al. Bipolar II disorder in patients with a current diagnosis of recurrent depression. Bipolar Disord. 2014;16:389-399.
Slyepchenko A, Frey BN, Lafer B, Nierenberg AA, Sachs GS, Dias RS. Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1.099 women from STEP-BD Study. Acta Psychiatr Scand. 2017;136:473-482.
McElroy SL, Frye MA, Hellemann G, et al. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. J Affect Disord. 2011;128:191-198.
Fornaro M, Perugi G, Gabrielli F, et al. Lifetime co-morbidity with different subtypes of eating disorders in 148 females with bipolar disorders. J Affect Disord. 2010;121:147-151.
Wildes JE, Marcus MD, Fagiolini A. Eating disorders and illness burden in patients with bipolar spectrum disorders. Compr Psychiatry. 2007;48:516-521.
Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord. 2010;12:404-413.
Galvez JF, Bauer IE, Sanches M, et al. Shared clinical associations between obesity and impulsivity in rapid cycling bipolar disorder: a systematic review. J Affect Disord. 2014;168:306-313.
Schag K, Schönleber J, Teufel M, Zipfel S, Giel KE. Food-related impulsivity in obesity and binge eating disorder-a systematic review. Obes Rev. 2013;14:477-495.
Mackinnon DF, Pies R. Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders. Bipolar Disord. 2006;8:1-14.
Perugi G, Fornaro M, Akiskal HS. Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? World Psychiatry. 2011;10:45-51.
Vieta E, Langosch JM, Figueira ML, et al. Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd). Int J Neuropsychopharmacol. 2013;16:1719-1732.
Samalin L, Guillaume S, Courtet P, Abbar M, Lancrenon S, Llorca PM. Methodological differences between pharmacological treatment guidelines for bipolar disorder: What to do for the clinicians? Compr Psychiatry. 2013;54:309-320.
Coryell W, Solomon D, Turvey C, et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry. 2003;60:914-920.
Barbuti M, Mainardi C, Pacchiarotti I, et al. The role of different patterns of psychomotor symptoms in major depressive episode: pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts. Bipolar Disord. 2019;21:785-793.
Brancati GE, Vieta E, Azorin J-M, et al. The role of overlapping excitatory symptoms in major depression: are they relevant for the diagnosis of mixed state? J Psychiatr Res. 2019;115:151-157.
Murru A, Guiso G, Barbuti M, et al. The implications of hypersomnia in the context of major depression: Results from a large, international, observational study. Eur Neuropsychopharmacol. 2019;29:471-481.
Verdolini N, Menculini G, Perugi G, et al. Sultans of swing: a reappraisal of the Intertwined Association Between Affective Lability and Mood Reactivity in a post hoc analysis of the BRIDGE-II-MIX Study. J Clin Psychiatry. 2019;80.
Vannucchi G, Medda P, Pallucchini A, et al. The relationship between attention deficit hyperactivity disorder, bipolarity and mixed features in major depressive patients: Evidence from the BRIDGE-II-Mix Study. J Affect Disord. 2019;246:346-354.
Barbuti M, Mazzarini L, Vieta E, et al. Relationships between recurrence and polarity in major depressive disorders: pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts. J Affect Disord. 2019;256:250-258.
Anmella G, Gil-Badenes J, Pacchiarotti I, et al. Do depressive and manic symptoms differentially impact on functioning in acute depression? Results from a large, cross-sectional study. J Affect Disord. 2020;261:30-39.
Perugi G, Pacchiarotti I, Mainardi C, et al. Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis. Eur Neuropsychopharmacol. 2019;29:825-834.

Auteurs

Maria Antonietta Furio (M)

Barcelona Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.

Dina Popovic (D)

Barcelona Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
Abarbanel Mental Health Center, Bat Yam, Israel.

Eduard Vieta (E)

Barcelona Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.

Yelena Stukalin (Y)

School of Behavioral Sciences, Tel Aviv-Yaffo Academic College, Tel-Aviv, Israel.

Michal Hagin (M)

Sheba Medical Center, Tel Hashomer University Hospital, Ramat Gan, Israel.

Carla Torrent (C)

Barcelona Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.

Jean-Michel Azorin (JM)

Hôpital Sainte-Marguerite, Marseille, France.

Jules Angst (J)

Psychiatrische Universitätsklinik, Zürich, Switzerland.

Charles L Bowden (CL)

University of Texas Health Center, San Antonio, TX, USA.

Sergey Mosolov (S)

Moscow Research Institute of Psychiatry, Moscow, Russia.

Allan H Young (AH)

King's College, London, UK.

Giulio Perugi (G)

University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH